Clinical Trials
5 trialsNCT03787602 2023-03-02
Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma
Kartos Therapeutics, Inc.
Phase 1/2 Unknown
NCT03750071 2022-10-20
VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma
Vaximm GmbH
Phase 1/2 Unknown
NCT02630368 2022-02-02
METROmaJX
Institut Bergonié
Phase 1/2 Unknown
NCT02767063 2020-08-07
ACTIW
Versailles Hospital
Phase 1/2 Unknown
NCT03844763 2020-03-03
CONFRONT
Gruppo Oncologico del Nord-Ovest
Phase 1/2 Unknown